Thu Thu Aung, MD
Allergy & Immunology · Brick, NJNPI 1558709865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 397 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,594, 5.9 times the $440 reported in 2019.
Across 397 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$1K
- GSK$829
- Regeneron Healthcare Solutions, Inc.$565
- Novartis$523
- Takeda Pharmaceuticals U.S.A., Inc.$450
- plus $3K from 33 others
What the payments were for
- Food & beverage$8,72899%
- Education$1221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 55 | $1,931 |
| Sanofi | 45 | $1,201 |
| GSK | 51 | $829 |
| Regeneron Healthcare Solutions, Inc. | 30 | $565 |
| Novartis | 34 | $523 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $450 |
| Biocryst US Sales Co., LLC | 17 | $372 |
| Grifols USA, LLC | 11 | $334 |
| Optinose US, Inc. | 16 | $253 |
| CSL Behring | 12 | $241 |
| Lilly USA, LLC | 8 | $241 |
| Genentech USA, Inc. | 7 | $233 |
| Aimmune Therapeutics, Inc. | 9 | $146 |
| Pharming Healthcare, Inc. | 4 | $136 |
| ADMA Biomanufacturing LLC | 1 | $120 |
| Galderma Laboratories, L.p. | 2 | $110 |
| Cycle Pharmaceuticals Inc | 4 | $107 |
| Covis Pharma GmbH | 6 | $100 |
| Kaleo, Inc. | 7 | $95 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $91 |
| Amgen | 6 | $88 |
| AbbVie | 5 | $74 |
| Greer Laboratories, Inc. | 3 | $71 |
| Octapharma USA, Inc. | 4 | $63 |
| Incyte Corporation | 4 | $63 |
| Ionis Pharmaceuticals, Inc. | 3 | $48 |
| Boehringer Ingelheim | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Pfizer | 2 | $32 |
| Phadia US Inc. | 2 | $25 |
| GC Biopharma USA, Inc. | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $18 |
| Organon | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Alk-abello, Inc | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,850 in reported general payments places this provider in the 70th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $19,832 |
| Epinephrine | 13 | $2,221 |
| Montelukast Sodium | 35 | $526 |
| Azelastine Hcl | 16 | $478 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $364 |
| Levocetirizine Dihydrochloride | 18 | $349 |
| Triamcinolone Acetonide | 11 | $169 |
| Prednisone | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere | $1,931 | $19,83214 claims |
| Hikma Pharmaceuticals USAEpinephrine | $16 | $2,22113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Brick
- Chirag PatelBrick$58K
- Bruce DecotiisBrick$38K
- Mary GeorgyBrick$10K
- Edward FernandezBrick$6K
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- Tina ZeccaLittle Silver$262K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.